Teva-Codeine · DIN 00593451 · 30 mg · tablet
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Teva-Codeine · DIN 00593451
Manufacturer: Teva Canada Limited; listing date 1996-10-01
Health Canada: Marketed since 2017-11-17 · brand TEVA-CODEINE · ATC R05DA04 CODEINE · form Tablet · route Oral · ingredients CODEINE PHOSPHATE 30 MG · company Chempex industries ltd. · schedule Narcotics (cdsa i)
Teva-Codeine: Formulary list price $0.10 per unit (the source does not state the unit; exact figure $0.0966). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00593451)
Source record
DIN 00593451: Teva-Codeine
Raw flags: sec3=Y
Item: 280808011; group id 400; item number 0956; lccId None; manufacturer id TEV
Source form: Tab; strength: 30mg
Recorded listing: General benefit
Source prices (unrounded): $0.0966; ministry $0.0966
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00593451
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=6416
Shortage status: not checked (no credentials)